Henry Schein, Inc. $HSIC Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D trimmed its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 11.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,992 shares of the company’s stock after selling 4,816 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Henry Schein were worth $2,629,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Steph & Co. acquired a new stake in shares of Henry Schein in the second quarter valued at about $44,000. CX Institutional raised its position in shares of Henry Schein by 107.3% in the second quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after buying an additional 337 shares during the last quarter. TD Private Client Wealth LLC grew its holdings in shares of Henry Schein by 103.0% in the second quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock valued at $49,000 after purchasing an additional 339 shares during the period. Whittier Trust Co. grew its holdings in shares of Henry Schein by 714.3% in the first quarter. Whittier Trust Co. now owns 798 shares of the company’s stock valued at $55,000 after purchasing an additional 700 shares during the period. Finally, Quarry LP purchased a new stake in shares of Henry Schein in the first quarter valued at about $71,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HSIC has been the subject of a number of analyst reports. Barrington Research reissued an “outperform” rating and issued a $78.00 price objective on shares of Henry Schein in a report on Wednesday, October 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Henry Schein in a report on Wednesday, October 8th. UBS Group dropped their price objective on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a report on Wednesday, August 6th. Wall Street Zen lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Leerink Partners set a $75.00 price objective on shares of Henry Schein in a report on Monday, July 14th. Five investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, Henry Schein has an average rating of “Hold” and a consensus price target of $76.67.

Henry Schein Stock Down 0.5%

Shares of HSIC opened at $63.21 on Wednesday. The stock has a market capitalization of $7.67 billion, a PE ratio of 20.39, a P/E/G ratio of 2.10 and a beta of 0.81. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The company’s 50-day simple moving average is $66.56 and its 200-day simple moving average is $68.57.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.